Janus Henderson Group PLC Bristol Myers Squibb CO Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,554,758 shares of BMY stock, worth $205 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,554,758
Previous 447,086
695.09%
Holding current value
$205 Million
Previous $18.6 Million
890.78%
% of portfolio
0.1%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.16 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.37 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.53 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...